!-- Google Tag Manager -->
Back to All Events

Clinical Trial Diversity & Intersectionality: Looking at the Whole Patient

In this session, an expert panel  with members representing a top 10 industry sponsor; a research and policy center; an independent nonprofit organization; and a pharmaceutical business intelligence provider  will share actionable insights on expanding the scope of diversity in clinical trials. The panelists will elaborate on the section of the new U.S. Food and Drug Administration (FDA) diversity plan guidance stating that "FDA advises sponsors to seek diversity in clinical trial enrollment beyond populations defined by race and ethnicity, including other underrepresented populations defined by demographics.

CEU: 1.00 ACRP

Speakers:

Watch a Sneak Peek into the Session Content: